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Abstract
Objective
In this study, we aimed to determine the correlation between the STONE score [(S)ize of the stone,
(T)opography or location, degree of (O)bstruction of the urinary system, (N)umber of stones, and
(E)valuation of Hounsfield units] and postoperative hemoglobin drop in patients undergoing percutaneous
nephrolithotomy (PCNL).
Methods
This was a prospective observational study and all adult patients aged 18-65 years undergoing unilateral,
single-tract PCNL using 26 Ch. Amplatz sheath for renal calculi were included. The five variables of the
STONE nephrolithometry score were calculated prior to the procedure. The stone-free rates were assessed on
imaging at four weeks and complications were graded using the modified Clavien system.
Results
Of the 142 patients included, 75% were below 55 years of age. More than half of our patients were diabetic
with more than 60% having a body mass index (BMI) above 25 kg/m2. The mean STONE score was 7 with 33%
having a high (>9) STONE score. The mean hemoglobin drop was 1.15 +0.92 g/dL with eight patients (5.63%)
requiring transfusion and one (0.7%) requiring angioembolization; one patient required readmission for
observation. Complete STONE clearance was achieved with PCNL alone in 78.2% of the patients. There was a
significant correlation of hemoglobin drop with the STONE score, stone size, and preoperative creatinine
clearance. Patients with a hemoglobin drop of >1 g/dL had a higher STONE score and mean stone size. The
overall complication rate was significantly higher (10.5%) in patients with a hemoglobin drop of >1 g/dL as
compared to those with a hemoglobin drop of <1 g/dL (2.8%).
Conclusion
Stone complexity as measured by the STONE score correlates with post-PCNL hemoglobin drop, stone
clearance, and complication rates. The STONE score may be used for preoperative counseling and to
evaluate the potential need for transfusion.
Categories: Urology
Keywords: stone nephrolithometry score, hemoglobin (hemoglobin) drop, percutaneous nephrolithotomy (pcnl)
Introduction
Percutaneous nephrolithotomy (PCNL) is considered to be the standard treatment for moderate to large-
sized renal calculi. It is minimally invasive and generally considered a safe and highly effective procedure.
However, serious complications, although rare, are encountered in patients with a complex stone burden.
Bleeding is common, although often minimal and self-limiting, and it can be life-threatening, requiring
transfusions and angioembolization in rare cases. The need for transfusion varies from 1-11% [1-4], and up
to 0.8% of the patients require angioembolization [5].
The predictors of postoperative bleeding include patient-related factors such as age [3], presence of diabetes
mellitus (both type 1 and 2) [4], urinary tract infections [3], and preoperative hemoglobin levels, and stone-
related factors such as large stones, staghorn calculi, stone location, the grade of hydronephrosis, and renal
parenchymal thickness [6]. Perioperative factors like multiple access and prolonged surgery time can also
influence postoperative bleeding [7].
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Stone complexity is one of the factors that correlate with postoperative hemoglobin drop. One of the
methods of measuring kidney stone complexity is the STONE score. The STONE score is calculated using five
variables, abbreviated as the acronym ‘S.T.O.N.E.’. These include stone size, tract length (skin-to-stone
distance), the degree of obstruction, the number of calyces involved, and stone essence (density) [8]. In their
study, Said et al. showed that complete and partial staghorn calculi were associated with a greater blood loss
compared to calyx stones [9]. They noted that stone complexity (Guy's Stone Score grades 3 and 4),
preoperative creatinine level (≥1.4 mg/dl), intraoperative complication (perforation and extravasation), and
duration of the operation (>83 minutes) were the most important factors associated with an increased risk of
bleeding and transfusion during PCNL. In another study, Syahputra et al. [7] concluded that a larger stone
burden or staghorn calculi required a greater amount of unit blood transfused during the PCNL procedure
compared to smaller stones.
Stone complexity is a known predictor of postoperative bleeding after PCNL; however, whether the STONE
score correlates with postoperative hemoglobin drop is not known. In this study, the correlation between the
STONE score and postoperative hemoglobin drop was assessed among patients undergoing PCNL [10]. We
hope our findings will help in counseling patients regarding transfusion requirement, hospital stay, and the
possible need for embolization.
Materials And Methods
We performed this non-randomized study at the department of urology of a university hospital. After
obtaining institutional review board and ethical review committee approval, all adult patients aged 18-65
years undergoing unilateral, single-tract PCNL using 26 Ch. Amplatz sheath for renal calculi were included
in the study. We excluded patients undergoing additional procedures such as transurethral resection of the
prostate/ureteroscopy (TURP/URS) along with PCNL; patients on anticoagulants, those with skeletal
deformity, and those undergoing mini PCNL procedures were also excluded. Surgery was performed in a
prone position under general anesthesia and the tract was dilated using serial metallic dilators. Stone
fragmentation was done with an ultrasonic probe using EMS™ or Lithoclast® Master (EMS, Nyon,
Switzerland). Smaller residual fragments were cleared using flexible nephroscope and laser. At the end of the
procedure, a 12 Fr Foley catheter with the balloon inflated or a 12 Fr Nelaton catheter was placed as a
nephrostomy tube at the discretion of the operating surgeon.
A senior radiologist (BS) at the workstation measured the variables such as stone size, tract length, degree
and presence of obstruction (hydronephrosis), number of involved calyces, and stone essence (density). Each
of the variables was scored according to the predefined system proposed by Okhunov et al. [8] and the
STONE nephrolithometry score was calculated.
The sample size of 142 was calculated with an assumed correlation of 0.7 between the STONE score and
hemoglobin levels, at a 5% level of significance, 80% power, and 10% inflation. The sample size was
calculated by NCSS PASS software version 11 (NCSS, LLC, Kaysville, UT). For data collection, a non-
probability continuous sampling technique was employed.
The primary outcome measure was postoperative hemoglobin drop, which was determined by calculating the
difference between preoperative and postoperative hemoglobin measured on the first postoperative day
after PCNL. Secondary outcomes were the number of blood transfusions required, the need for
angioembolization within 30 days of the procedure, length of hospital stay, and 30-day complications
according to modified Clavien grade.
Data were analyzed using SPSS Statistics version 25 (IBM, Armonk, NY). Continuous variables such as age,
body mass index (BMI), and the STONE score were described in terms of mean/median and standard
deviations. For post-hemoglobin drop, mean difference (preoperative and postoperative hemoglobin) was
reported and assessed by paired t-test. Categorical variables such as gender were described in terms of
frequencies and percentages. The correlation between the STONE score and postoperative hemoglobin drop
was measured by the Pearson correlation/Spearman correlation coefficient as appropriate.
Results
The basic demographics details are presented in Table 1. The STONE score and its individual parameters are
shown in Table 2.
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Parameters Frequency (N=142) Mean (±SD/%)
Age (years)   44.54 ±14.3
Gender
Male 87 61%
Female 55 39%
Comorbidities
DM 75 52.81%
HTN 80 56.30%
Hospital stay (days)  2.39 ±0.68
BMI, kg/m2
Total 142 27.26 ±5.45
Underweight 8 5.60%
Normal (BMI of 18-25) 44 30.90%
Overweight 51 35.90%
Obese 39 27.60%
Smoker  25 17.60%
Side of surgery
Left 79 55.20%
Right 63 44.80%
Preoperative hemoglobin/hematocrit  13.45 ±2.0/41.62 ±5.47
Postoperative hemoglobin/hematocrit  12.30 ±1.97/37.70 ±5.20
Preoperative creatinine  1.00 ±0.38
History of stone surgery 48 34%
Postoperative double J stent 33 23%
TABLE 1: Demographic details and baseline stone-related and clinical parameters
SD: standard deviation; DM: diabetes mellitus; HTN: hypertension; BMI: body mass index
Variables Mean ±SD Correlation coefficient P-value
Total STONE score 7.56 ±1.64 0.16 0.05
Stone size (mm2) 381 ±200 0.49 0.03
Tract length (mm) 80.63 ±20.40 -0.09 0.26
Stone density (Hounsfield units) 910.3 ±358.9 0.001 0.99
TABLE 2: Correlations of the STONE scores and individual parameters with hemoglobin drop
STONE: size of the stone, topography or location, degree of obstruction of the urinary system, number of stones, and evaluation of Hounsfield
units; SD: standard deviation
Of the 142 patients included, 75% were below 55 years of age. More than half of our patients were diabetic
with more than 60% having a BMI above 25 kg/m2. Almost all of our patients had normal preoperative
hemoglobin (60% with a hemoglobin level of >13 g/dl). The mean STONE score was 7.12 with 33% having a
high (>9) STONE score. This complexity is attributable to the presence of moderate/severe hydronephrosis
and the involvement of more than three calyces in >50% of our patients. Overall mean hemoglobin drop was
low (1.15 +0.92) in our patients with only eight (5.6%) requiring transfusion and only one (0.7%) requiring
angioembolization. One of the patients required readmission and was managed conservatively with bed-
rest. Complete STONE clearance was achieved with PCNL alone in 78.2% of the patients. Ancillary
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procedures for the residual stones were needed in 18 patients (12.7%) (Table 3).
Parameters Number of patients ±SD/%
Mean hemoglobin/hematocrit drop  1.15 ±0.92/4.14 ±3.93
Blood transfusion 8 5.63%
Hematuria >24 hours 4 2.92%
Angioembolization 1 0.70%
Complications 19 13.38%
Readmission 1 0.70%
Fever 5 3.52%
Stone clearance 111 78.16%
Lost to follow-up 8 5.63%
Residual stone
Total 23 16.19%
Shockwave lithotripsy 11 7.15%
Ureteroscopy 6 4.22%
Open stone surgery 1 0.70%
Observation 5 4.12%
TABLE 3: Outcome parameters including ancillary treatment for residual stones
SD: standard deviation
There was a significant correlation of hemoglobin drop with the total STONE score, stone size, and
preoperative creatinine clearance (Table 4). Patients with a hemoglobin drop of >1 g/dl had a higher STONE
score and stone size. Overall the complications were higher (10.5%) in patients with a hemoglobin drop of >1
g/dl as compared to those with a hemoglobin drop of <1 g/dL (2.8%) (Table 5).
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  Number of patients ±SD/%
STONE score
Mean  7.56 ±1.64
Low (4-5) 19 13.38%
Moderate (6-8) 75 52.82%
High (>9) 48 33.80%
Stone size (mm2)
Mean  380.97 ±199.82
0-399 91 64.08%
400-799 46 32.39%
800-1,599 5 3.53%
Tract length (mm)
Mean  80.63 ±20.40
<100 115 81%
>100 27 19%
Obstruction
No/mild 57 40.14%
Moderate/severe 85 59.96%
Calyces involved (n)
1-2 61 42.15%
3 36 25.35%
Staghorn 45 31.70%
Stone density (Hounsfield units)
Mean  910.28 ±358.86
<950 67 47.18%
>950 75 52.82%
TABLE 4: Stone-related parameters, calyces involved, and degree of obstruction
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 Hemoglobin drop of <1 Hemoglobin drop of >1 P-value
Female (n) 24 31 0.62
Males (n) 43 44 0.7
Age (years) 46.21 43.04 0.19
BMI 27.61 26.94 0.46
Preoperative hemoglobin (gm/dl) 13.19 13.7 0.14
Postoperative Hemoglobin (gm/dl) 12.73 11.93 0.02
Preoperative creatinine (mean, mg/dl) 1.04 0.97 0.28
Nondiabetic (n) 29 38 0.48
Diabetes present (n) 38 37 0.48
Nonhypertensive (n) 34 46 0.27
Hypertensive (n) 33 29 0.27
Non-smoker (n); smoker (n) 55; 12 57; 18 0.5
Left side (n) 39 40 0.68
Right side (n) 39 40 0.68
STONE score (mean) 7.12 8.03 0.04
Stone size (mm2) 219.81 468.71 0.03
Tract length (mm) 81.95 79.45 0.74
TABLE 5: Comparison of the groups regarding various outcome parameters in patients who had <
or >1 gm/dl hemoglobin drop
BMI: body mass index
Discussion
Hematuria is one of the most dreaded complications of PCNL. Mostly it is mild and self-limiting, however,
occasionally it could be life-threatening. Ultrasound-guided access [10], miniaturization of the instruments
[11], use of the balloon catheter nephrostomy tube [12], and tubeless PCNL with the use of tract sealant [13]
are some of the ways described to minimize bleeding complications. Various patient and stone-related
factors have also been studied to predict PCNL complications including previous interventions [14]. Various
nephrolithometry scoring systems have been described to objectively quantify the parameters. In this study,
we have attempted to correlate one of the most commonly used scoring systems, i.e., the STONE score, to
predict bleeding complications of PCNL.
The correlation of the STONE score with postoperative hemoglobin drop has not been previously assessed in
contemporary literature. Most of the previous studies have correlated the STONE score with estimated blood
loss (EBL), which is often difficult to quantify. However, hemoglobin drop is a more objective way of
assessing blood loss as compared to EBL.
Our study showed that there is a significant correlation between the STONE score and hemoglobin drop
(p=0.05). Okhunov et al. [8] noted that the STONE score has a significant association with EBL (p=0.005)
during PCNL. Another study by Yarimoglu et al. [15] showed no significant association between the STONE
score and EBL. The mean hemoglobin drop was 1.15 ±0.92 in our study, which is similar to a recent study by
Jamil et al. [12] comparing Foley and Nelaton™ catheter nephrostomy tubes. However, they noted no
significant difference in the mean hemoglobin drop in the two groups with balloon versus non-balloon
catheter nephrostomy respectively (1.08 ±0.7 and 1.14 ±0.69). Said et al. [9] noted a hemoglobin drop of 1.5
±1 g/dl in the treatment of staghorn stones, which is comparatively higher than our hemoglobin drop;
similarly, they noted a 14% blood transfusion rate as compared to only 5.63% in our study. Indication of a
complex stone burden may be associated with greater blood loss. Hemoglobin drop of >1 g/dl was noted in
patients with a STONE score of more than 8.03 as compared to a STONE score of less than 7.12 (p=0.04).
Most patients with complications (15 out of 19), had a hemoglobin drop of >1 g/dl (p 0.04), which further
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implies that the increase in stone complexity shown by the STONE score is correlated with both the
complications and blood loss. Our results showed that hemoglobin drop is also associated with stone size
(p=0.03), which is similar to Okhunov et al.'s [8] study findings (p=0.047). Other individual components of
the STONE score like skin-to-stone distance, stone density, and the presence of hydronephrosis did not show
any significant association with hemoglobin drop in our study. This result is also similar to the findings of
Okhunov et al. [8].
Another noteworthy observation in the current work is that a postoperative hemoglobin drop of >1
g/dl correlated with higher preoperative hemoglobin (13.7 g/dl) and lower preoperative creatinine (0.97
mg/dl). Hemoglobin drop was 1.76 g/dl with mean preoperative hemoglobin of 13.7 g/dl as compared to a
drop of only 0.46 g/dl with mean preoperative hemoglobin of 13.2g/dl. This can be an incidental finding with
a statistical significance and needs to be analyzed further in order to understand its clinical significance.
In our study, the mean hemoglobin drop was 1.15 ±0.92, and the mean hematocrit drop was 4.14 ±3.93. A
previous study done by Zehri et al. [16] at the same institute showed a mean hemoglobin drop of 1.68 ±1.3
gm/dl, which indicates that the overall hemoglobin drop has decreased with time. Total blood transfusion in
our current study has decreased to 5.63% (n=8) and only one patient (0.70%) required angioembolization.
Zehri et al. [16] reported a higher transfusion rate of 14.2% (n=33) with one of the patients (0.43%) requiring
angioembolization [16].
At the authors’ institution, all PCNLs are performed in the prone position and under general anesthesia.
We predominantly use an ultrasonic probe for fragmentation or Lithoclast® Master with both ultrasound
and pneumatic lithotripsy. The laser is not used for standard PCNL, except in a situation where a flexible
nephroscope is used to overcome the difficulty to reach the caliceal fragment. Although regional and local
anesthesia is also described for performing PCNL, in the current work, only general anesthesia was used.
This, in our view, does not cause any limitations but limits the use of PCNL in patients who are ineligible for
general anesthesia. However, it provides standardization in assessing outcomes in the current study.
The major strength of this study is that it is the first in-depth study correlating the STONE score with
hemoglobin drop. We have included all types of patients, ranging from those with simple kidney stones to
those with complicated ones. The major limitation of this study was that it was a monocentric study, with a
relatively small sample size and short-term follow-ups. However, we believe that the results of this study
will help in preoperative counseling of patients about the need for transfusions, hospital stay, and
complications.
Conclusions
Based on our findings, stone complexity as measured by the STONE score correlates with post-PCNL
hemoglobin drop, stone clearance, and complications. Therefore, the STONE score can be used for
preoperative counseling and to determine potential blood requirements.
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